*EP Impurity P CAS: 123967-58-8

Dongguan Jingyuan Experimental Technology Co., Ltd. mainly provides pharmaceutical impurity reference standards for major pharmaceutical production and research and development enterprises, inspection institutions, scientific research institutions, etc. in China, and provides customized drug impurity reference standards services for customers. Welcome to inquire!158-128-17678 Manager Chen.

*Introduction to EP Impurity P Standard (COA and spectrum are attached in the data, welcome to download and learn about the product information):

Product Name: * EP Impurity P
English name: Clarithromycin EP Impurity P
CAS：123967-58-8
Molecular formula: C39H71NO
Molecular weight: 761.97
Synonyms：4'',6-Di-O-MethylerythroMycin
Specifications: 10mg, 25mg, 50mg, 100mg Purity: 96%+Delivery time: In stock
Structural formula:

Purpose: Drug declaration and testing. We offer a complete range of impurities, including COA quality inspection reports, hydrogen spectra, mass spectrometry, liquid chromatography (HPLC), as well as carbon spectra, ultraviolet, infrared, and two-dimensional spectra.
If needed, please contact me. I can provide you with impurity chemical structural formulas and CAS numbers for many projects. These impurity structural formulas are very helpful for your company's R&D personnel. R&D personnel can see many popular impurity structural formulas for projects on our website, which can reduce the time for your company's R&D personnel to speculate on chemical structural formulas.

AMO Sciences, Inc. is a comprehensive service provider for Contract Research Organizations (CROs), providing expertise in custom synthesis (impurities), analytical research (method development, validation), stability studies, formulation and development (new drug delivery systems).

Quality assurance and regulatory services are seamlessly integrated with competent talent, * infrastructure, * technology, and certified processes, providing time and cost advantages for your development process.

Our expertise also enables you to strive and win special market segments in a fiercely competitive market. We hope to become your outsourcing strategic partner and help you accelerate the filing and agency of NDAs and ANDAs submitted in any regulated and semi regulated market, from the strategic planning of CMC blueprints, which can reduce your time and energy and focus on them in your core operational areas.

Since its establishment in 2006, AMO has been providing services to clients including large pharmaceutical companies, API manufacturers, API suppliers, clinical CROs, and other related industries. The effectiveness of our successful service delivery stems from our efforts to carry out projects efficiently, on time, and at a reasonable cost.